| Home
> Table of Contents
> Original / Research
Articles |
| |
A Study of Paraneoplastic Syndrome Patterns
in Patients with Bronchogenic Carcinoma in a Peripheral General
Hospital of Kuwait
Thomas A Vurgese, Sunil R Bahl, Osman A Mapkar |
| |
Context : Paraneoplastic syndromes
which are the distant effect of underlying carcinoma can present
early, well before the primary lung lesion produces local symptoms
and even when the tumour is undetected or very small. Paraneoplastic
syndromes are common in patients with bronchogenic carcinoma.
They may be the presenting finding or the first sign of recurrence.
Aims : To assess the incidence and
pattern of Paraneoplastic syndrome (PNS) in patients with bronchogenic
carcinoma in a peripheral hospital of Kuwait.
Settings and Design : The four medical
wards comprising 140 beds in a 480 bedded general hospital in
Kuwait. Retrospective study of patients with a confirmed diagnosis
of bronchogenic carcinoma admitted from January 2000 to June
2004.
Material and Methods : The Medical
records of all the confirmed cases of bronchogenic carcinoma
admitted to Al Jahra hospital between January 2000 and June
2004 were reviewed. The clinical and biochemical parameters
recorded were : age, sex, underlying medical illness, presentation
complete blood count, blood urea, electrolytes and serum calcium
levels, and appropriate hormone levels when indicated. The localization
of the tumours was done by chest X-ray and CT scan. Tissue biopsy
was obtained by bronchoscopy or under CT scan guidance and histopathological
examination of the specimen was carried out. The type and pattern
of PNS if any was noted. These parameters were entered into
a database and later analyzed. A retrospective study of 52 confirmed
bronchogenic carcinoma patients occurring from January 2000
to June 2004 in our hospital was carried out.
Statistical analysis used : The data management and statistical
package used was Epi Info version 6 distributed readily by the
CDC (Centre for Disease Control) Bethesda, USA.
Results : Out of 52 patients, 49 were
male and 3 were females. All were heavy smokers or ex-smokers.
The histological types were 22.4% small cell carcinoma and 67.6%
non-small cell carcinoma. The mean age was 67.46 ± 12.15
years. Associated illness found was DM - 45.5%, Hypertension
63.6% and COPD - 27.3%. Almost all the patients presented with
cough - 100%, SOB - 99%, haemoptysis - 42%, pleural pain - 31.5%
and fever - 42% and weight loss 75%. The PNS found were : Hypercalcaemia
- 42%, thrombosis - 9.1%, limbic encephalitis - 5.8%, SIADH
- 5.8%, Peripheral neuropathy - 3.8%, GBS - 1.9%, Pancytopenia
- 5.8%. There was no case with ACTH secretion or Lambert-Eaton
Syndrome.
Conclusions : Hypercalcaemia, thrombocytosis,
SIADH, pancytopenia, limbic encephalitis and other unexplained
neurological problems occurring in the middle aged or elderly
smokers should arouse the suspicion of an occult bronchogenic
carcinoma.
|
| |
| INTRODUCTION |
The prevalence of smoking among Kuwaitimen is very
high and a large number of them are heavy smokers.1 The
number of women smokers is also steadily going up. Hence
the incidence of bronchogenic carcinoma is very high.
It is also the cancer with the highest incidence of paraneoplastic
syndromes.2 PNS is a constellation of signs and symptoms
that are not due to direct effect of the tumour or its
metastasis but occurs due to the hormones or other chemicals
produced by the tumour. As PNS may be the initial presentation
even before the manifestations of the tumour, a high degree
of suspicion is required for early diagnosis and treatment
leading to a better prognosis.3 The purpose of the study
was to determine the pattern of PNS in patients with bronchogenic
carcinoma admitted at A1 Jahra hospital - a 480 bed peripheral
general hospital in Kuwait. |
| |
| Material and Methods |
The Medical records of all confirmed cases of bronchogenic
carcinoma admitted to A1 Jahra hospital between January
2000 and June 2004 were reviewed. The clinical and biochemical
parameters recorded were : age, sex, underlying medical
illness, presentation, complete blood count, blood urea,
electrolytes and serum calcium levels. The localization
of the tumours was done by chest X-ray and CT scan. Tissue
biopsy was obtained by bronchoscopy or under CT scan guidance
and histopathological examination of the specimen was
carried out. The type of PNS if any was noted. These parameters
were entered into a database and later analyzed. The data
management and statistical package used was Epi Info version
6 distributed readily by the CDC (Centre for Disease Control)
Bethesda, USA. |
| |
| Results |
A total of 52 patients were studied comprising 49 males
and 3 females - all of them heavy smokers or ex-smokers.
The mean age was 67.46 ± 12.15 years. Associated
illnesses were : Diabetes Mellitus 45.5%, Hypertension
63.6%, COPD 27.3%. All the patients presented with cough,
99% with shortness of breath, 42% with haemoptysis, 31.5%
with pleural pain, 42% with fever, 75% with weight loss.
The patients who presented with signs symptoms and laboratory
evidence of PNS were : 42% with hypercalcemia, 9.6% with
thrombocytosis, 5.8% with limbic encephalitis or SIADH,
3.8% with peripheral neuropathy, 1.9% with GBS and 5.8%
with pancytopenia.
In our study there were no patients who presented with
ectopic ACTH secretion, myasthenia gravis or Lambart -
Eaton myasthenic syndrome.
The histopathological type of the bronchogenic carcinoma
were : 22.4% small cell carcinoma and 67.6% non-small
cell carcinoma. |
| |
| Discussion |
The fact that bronchogenic carcinoma is caused by carcinogens
and tumour promoters ingested by cigarette smoking is
fully corroborated in this study where almost 100% patients
were either heavy smokers or ex-smokers. The relative
risk of developing bronchogenic carcinoma increases 13
fold by active smoking or ~1.5% by passive exposure to
cigarette smoke.
 |
Paraneoplastic syndromes which are the distant effect of underlying carcinoma can present early, well before the primary lung lesion produces local symptoms and even when the tumour is undetected or very small. The signs and symptoms of the hormones and biochemical agents produced by the bronchogenic carcinoma can be detected early by clinical and biochemical means.3 Bigger the tumour, more florid are the signs and symptoms of PNS. The diagnosis of occult tumour associated with PNS requires a high degree of suspicion, but still on some occasions it may be difficult and may lead to delay in initiation of treatment.3
Hypercalcaemia is the commonest PNS of bronchogenic carcinoma
and is most commonly associated with the squamous cell
carcinoma type, but can be associated with the other non-small
cell bronchogenic carcinomas. Hypercalcaemia is uncommon
at presentation4 but becomes apparent as the tumour progresses.4
Its pathogenesis is related to hormone production and
is called humoral hypercalcaemia of malignancy. In our
study hypercalcaemia was present in 43% of the patients
which correlates well with the other studies. Another
hormone that is produced by bronchogenic carcinoma is
ADH.5 The syndrome of inappropriate ADH (SIADH) secretion
is easily diagnosed by clinical and biochemical means.
It results in hypotonic euvolaemic hyponatraemia with
urinary hyperosmolarity. It is most commonly associated
with small cell bronchogenic carcinoma and is caused by
release of argenine vasopression (AVP) hormone. The incidence
of SIADH of 5.8% correlates well with the other studies.
Sign and symptoms may precede the tumour by many months
or years.6,7 In our study limbic encephalitis presented
as intractable epilepsy and the small tumours were detected
due to the high index of suspicion. There is evidence
that neoplastic neurological symptoms are immune mediated
(anti-Yo antibodies).8,9 Treatment is directed towards
the primary tumour and the PNS may remit with the regression
of the tumour. |
 |
Thrombocytosis is the commonest paraneoplastic haematological
abnormality with some studies reporting incidence up to
50%.10 In our study the incidence of thrombocytosis was
9.1%. Two of our cases had pancytopenia with hypercellular
marrow as in the cases reported by Raz et al.12,13 The
other haematological PNS reported is Erythrocytosis due
to increased Erythropoietin secretion by the tumour.14
We had no report of erythrocytosis in our study.
Since PNS can be the presenting feature of bronchogenic
carcinoma, it is imperative to have a high index of suspicion
and to investigate these patients fully with all available
facilities. The use of 18-F fluorodeoxyglucose positron
emission tomography ((U8)F-FDG-PET) has further helped
in directing small occult tumours. |
|
| |
| Conclusion |
Paraneoplastic syndromes are common in patients with
bronchogenic carcinoma from Al Jahra region of Kuwait.
These patients, clinically presented with hypercalcaemia,
thrombocytosis, SIADH or limbic encephalitis. It is therefore
important to consider the possibility of bronchogenic
carcinoma in smokers who present with signs, symptoms
and biochemical evidence of paraneopalstic syndromes and
to investigate them thoroughly. |
| |
| Acknowledgement |
We express our thanks to Mr. Sunny J Parackal for his
help in typing this manuscript. |
| |
References
| 1. |
Mewan A, Moody PM, Sugratan TN, el-gerges
N, al-Buetan M, al-snatti A, al-Jazzat H. Bull World
Health Organ 2000; 78 (11) : 1306-15. |
| 2. |
Ende and E. Paraneoplastic syndromes.
Am J Hospital Palliate Care 2004; 21 (2) : 85-6. |
| 3. |
Van Wichest P. Paraneoplastic syndrome.
Problems and Importance of early diagnosis and treatment
of neoplasms. Med Klin 1971; 66 (43) : 1461-5. |
| 4. |
Oura S. Malignancy associated hypercalcemia.
Nippon Rinsho 2003; 61 : 1006-9. |
| 5. |
Van Roh, Cerny T, Jos SR, Brumer K.
SIADH in small cell Bronchial Carcinoma, Scheneiz
Med Wodensche. 1991; 121 (36) : 1271-82. |
| 6. |
Bataller L, Dalmau J. Panneoplastic
neurologic syndromes : approaches to diagnosis and
treatment. Semin Neurol 2003; 23 : 215-14. |
| 7. |
Voltz R. Paraneoplastic
neurological syndromes : an update on diagnosis, pathogenesis,
and therapy. Lancet Neurol 2002; 1 : 294-305. |
| 8. |
Finster J, Bodenteich A,
Drlicek M. Atypical Paraneoplastic syndrome associated
with anti-Yo antibodies. Clin Neuropathol 2003; 22
: 137-40. |
| 9. |
Shams’ ili S, Grefkens
J, de Leeuw B, et al. Paraneoplastic cerebellar degeneration
associated with antineuronal antibodies : analyses
of 50 patients. Brain 2003; 126 : 1409-18. |
| 10. |
Pedersen LM, Milman N.
Diagnostic significance of platelet count and other
blood analysis in patients with lung cancer. Oncol
Rep 2003; 10 : 213-16. |
| 11. |
Johnson RA, Roodman GD.
Hematologic manifestation of malignancy. Dis Mon 1869;
35 : 721-68. |
| 12. |
Raz I, Shinar E, Polliack
A. Pancytopenia with hypercellular bone marrow - a
possible paraneoplastic syndrome in carcinoma of the
lung : a report of three cases. Am J Hematol 1984;
16 : 403-8. |
| 13. |
Koistinen P, Kinnula V,
Timonen T. Aplastic anaemia as a paraneoplastic syndrome
in lung cancer. Eur J Cancer 1990; 26 : 651. |
| |
|
|
STATEMENT BY THE PUBLISHERS
FORM IV (RULE 8)
Statement about ownership and other particulars about the newspapers to be published in the first issue every year after the last day of February.
-
Name of Publication : BOMBAY HOSPITAL JOURNAL
- Place of Publication : Bombay Hospital Trust,12,Marine Lines, Mumbai-400 020.
- Period of Publication : Quarterly.
- Printer’s name : Dr. R.J.Mehta
Nationality : Indian.
Address : Bombay Hospital Journal, 4th Floor, 12, Marine Lines,
Bombay Hospital Complex, Mumbai-400 020
- Publisher’s name : Dr. R.J.Mehta
Nationality : Indian
Address : Bombay Hospital Journal, 4th Floor, 12, Marine Lines,
Bombay Hospital Complex, Mumbai-400 020.
- Editor’s name : Dr. O.P.Kapoor
Nationality : Indian.
Address : Bombay Hospital Journal, 4th Floor, 12, Marine Lines,
Bombay Hospital Complex, Mumbai-400 020.
- Names and addresses of individuals who own the newspapers and partners or
shareholders holding one or more than one per cent of the total capital
I, Dr.R.J.Mehta, hereby declare that the particulars given above are true to the best of my knowledge and belief.
Date : 1.4.2005. Dr.R.J.Mehta
Signature of Publisher
|
| |
|
| |
|
|